The Atherogenic Index of Plasma independently predicts the onset and progression of cardio-renal-metabolic multimorbidity.
Does the Atherogenic Index of Plasma predict the onset and progression of Cardio-Renal-Metabolic multimorbidity?
The Atherogenic Index of Plasma may serve as a simple, low-cost tool for early risk stratification and prevention of cardio-renal-metabolic multimorbidity.
Absolute Event Rate: 0% vs 0%
AIP is an independent, simple, and low-cost predictor of CRM onset and progression, with potential utility for early risk stratification and prevention.
Jin et al. (Wed,) reported a other. The Atherogenic Index of Plasma independently predicts the onset and progression of cardio-renal-metabolic multimorbidity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: